Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Rating) shares shot up 2.5% on Tuesday . The company traded as high as $138.32 and last traded at $137.94. 344 shares traded hands during trading, a decline of 65% from the average session volume of 990 shares. The stock had previously closed at $134.61.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the company. Berenberg Bank raised Carl Zeiss Meditec from a “hold” rating to a “buy” rating in a research note on Wednesday, October 5th. Deutsche Bank Aktiengesellschaft lifted their price target on Carl Zeiss Meditec from €156.00 ($167.74) to €167.00 ($179.57) and gave the stock a “buy” rating in a research report on Monday, October 31st.
Carl Zeiss Meditec Stock Performance
The business has a 50-day moving average price of $130.13 and a two-hundred day moving average price of $126.11.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.
- Get a free copy of the StockNews.com research report on Carl Zeiss Meditec (CZMWY)
- Is Salesforce’s New Rally The Beginning Of A Big Uptrend?
- Can Lockheed Martin Corporation Hit Another All-Time High in Q1?
- Marathon Digital Holdings, Inc: Slow And Steady Wins The Race
- The WD-40 Company Is Ready To Rebound, But Will It?
- Skechers Not Nike Is The Sneaker Stock to Own for 2023
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.